In cancer cells, aberrant HGF/c-Met axis triggering, which is strongly linked to c-Met gene mutations and amplification, promotes tumor development/progression by inducing the PI3K/AKT, Ras/MAPK, JAK/STAT, SRC, Wnt/β-catenin, and other signaling pathways. Here, SRC is linked to cancer.